Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		MARSH & McLENNAN COMPANIES, INC.

Dated:	February 13, 2023	By	/S/ JOHN Q. DOYLE
			John Q. Doyle President and Chief Executive Officer

Each person whose signature appears below hereby constitutes and appoints Courtenay Birchler and Connor Kuratek, and each of them singly, such person’s lawful attorneys-in-fact and agents, with full power to them and each of them to sign for such person, in the capacity indicated below, any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated this 13th day of February, 2023.


Name	Title	Date

/S/ JOHN Q. DOYLE John Q. Doyle	Director, President & Chief Executive Officer	February 13, 2023

/S/ MARK C. MCGIVNEY Mark C. McGivney	Chief Financial Officer	February 13, 2023

/S/ STACY M. MILLS Stacy M. Mills	Vice President & Controller (Chief Accounting Officer)	February 13, 2023

/S/ ANTHONY K. ANDERSON Anthony K. Anderson	Director	February 13, 2023

/S/ HAFIZE GAYE ERKAN Hafize Gaye Erkan	Director	February 13, 2023

/S/ OSCAR FANJUL Oscar Fanjul	Director	February 13, 2023

/S/ H. EDWARD HANWAY H. Edward Hanway	Director	February 13, 2023

/S/ DEBORAH C. HOPKINS Deborah C. Hopkins	Director	February 13, 2023

/S/ TAMARA INGRAM Tamara Ingram	Director	February 13, 2023

/S/ JANE H. LUTE Jane H. Lute	Director	February 13, 2023

/S/ STEVEN A. MILLS Steven A. Mills	Director	February 13, 2023

/S/ BRUCE P. NOLOP Bruce P. Nolop	Director	February 13, 2023

/S/ MORTON O. SCHAPIRO Morton O. Schapiro	Director	February 13, 2023

/S/ LLOYD M. YATES Lloyd M. Yates	Director	February 13, 2023

/S/ R. DAVID YOST R. David Yost	Director	February 13, 2023

Previous: Item 15. Exhibits and Financial Statement Schedules. †